Stem Cell Breakthrough To Transform Transplants: Melbourne researchers have made a world first breakthrough into creating blood stem cells that closely resemble those in the human body. And the discovery could soon lead to personalised treatments for children with leukaemia and bone marrow failure disorders. The research, led by Murdoch Children’s Research Institute (MCRI) and […]
Read More… from Stem Cell Breakthrough To Transform Transplants
Leukaemia Warning Symptoms: Only 14% of Brits know the warning signs of leukaemia as thousands are diagnosed in A&E every year. Leukaemia charities highlight the urgent need to raise awareness of signs and symptoms to stop the deadly blood cancer devastating lives. New research has revealed that a mere 14% of UK adults know the […]
Read More… from Low Awareness of Leukaemia Symptoms Puts Lives at Risk
Gastric cancer: Biomarkers identified to predict the risk of relapse: Surgical removal of the tumour is considered the basis for curing gastric cancer. However, 40 per cent of patients who have undergone surgery suffer a relapse within two years. A research team led by MedUni Vienna has now investigated a prognostic marker that can be […]
Read More… from Gastric cancer: Biomarkers identified to predict the risk of relapse
The Top Journal Lancet Haematology recently published an international trial on a blood thinner to treat blood clots in children. Principal investigator was Christoph Male from the Department of Paediatrics and Adolescent Medicine, MedUni Vienna. He was now invited by Lancet Haematology to write a ‘Debate Article’ to give his view on the usefulness of […]
Read More… from Are clinical trials of anticoagulation feasible in children?
Leukaemia treatment can be made more effective by using a drug for iron overload, according to new research. Scientists led by a team at Imperial College London have found that chemotherapy for one type of leukaemia could be improved by giving patients a drug currently used to treat an unrelated condition. Acute myeloid leukaemia (AML) […]
Researchers are looking for ways eliminate the need for bone marrow donors altogether and instead use different types of cells derived from the patient in need of a transplant, says Dr Vladislav Sandler. At the moment, people who develop leukaemia, lymphoma and other blood diseases often need to undergo a hematopoietic stem cell transplantation (“HSCT”). This […]
Can we eliminate the need for bone marrow donors? There is a chance that we can. At the moment, people who develop leukaemia, lymphoma and other blood diseases often need to undergo a hematopoietic stem cell transplantation (“HSCT”). This is because initial treatment of the disease (front-line therapy) often fails and the disease comes back. […]
Leukaemia is a cancer of the blood with a high mortality rate, partly due to the fact that leukaemia cells show a remarkable ability to survive initial chemotherapy treatments. These surviving cells are often resistant to treatment, allowing the cancer to spread and become fatal. It has always been thought that the leukaemia cells saved […]